APA (7th ed.) Citation

Matuszewska, K., ten Kortenaar, S., Pereira, M., Santry, L. A., Petrik, D., Lo, K., . . . Petrik, J. (2022). Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer. Gynecologic Oncology, 164(1), 154. https://doi.org/10.1016/j.ygyno.2021.11.006

Chicago Style (17th ed.) Citation

Matuszewska, Kathy, et al. "Addition of an Fc-IgG Induces Receptor Clustering and Increases the in Vitro Efficacy and in Vivo Anti-tumor Properties of the Thrombospondin-1 Type I Repeats (3TSR) in a Mouse Model of Advanced Stage Ovarian Cancer." Gynecologic Oncology 164, no. 1 (2022): 154. https://doi.org/10.1016/j.ygyno.2021.11.006.

MLA (9th ed.) Citation

Matuszewska, Kathy, et al. "Addition of an Fc-IgG Induces Receptor Clustering and Increases the in Vitro Efficacy and in Vivo Anti-tumor Properties of the Thrombospondin-1 Type I Repeats (3TSR) in a Mouse Model of Advanced Stage Ovarian Cancer." Gynecologic Oncology, vol. 164, no. 1, 2022, p. 154, https://doi.org/10.1016/j.ygyno.2021.11.006.